California Cancer Reporting System Standards, Volume III

 

retired

IF781: CS Tumor Size/Ext Eval, Surgery (CS)

Edit Sets:

California Hospital Transmit

Eureka Admission Level

Eureka Tumor Level

Fields:

Primary Site  [NAACCR #400]

Histologic Type ICD-O-3  [NAACCR #522]

Behavior Code ICD-O-3  [NAACCR #523]

CS Tumor Size/Ext Eval  [NAACCR #2820]

RX Summ--Surg Prim Site  [NAACCR #1290]

RX Summ--DX/Stg Proc  [NAACCR #1350]

CS Site-Specific Factor25  [NAACCR #2879]

Message:

IF 781:  Conflict among schema, CS Tumor Size/Ext Eval ("value"), RX Summ--Surg Prim Site ("value"), RX Summ--DX/Stg Proc ("value")

Specification:

This edit is skipped if any of the following conditions are true:

  1. CS Tumor Size/Ext Eval is not = 3

  2. Behavior Code ICD-O-3 = 0 (benign) or 1 (borderline) and schema is not Brain, CNSOther, or IntracranialGland

  3. CS schema is invalid

This edit first determines the correct CS schema by doing a function call to the CS Dynamic Link Library (dll). The function call passes Primary Site, Histologic Type ICD-O-3, and CS Site-Specific Factor25 (schema discriminator) to the dll and the CS schema name is returned.

The remaining logic is skipped if the schema is Lymphoma or Prostate.

This edit applies only to cases with CS Tumor Size/Ext Eval code = 3.

The definition of code 3:

The edit logic:

If CS Tumor Size/Ext Eval = 3, then either RX Summ--Surg Prim Site must = 20-90, indicating patient had a surgical procedure, or RX Summ--DX/Stg Proc must = 01, 02, 05, 06, 07, indicating patient had a biopsy.

Historical Changes:

10/10/07:  SEER requiring Eval fields for 2008+ diagnosed cases.  

2/20/08:  Definiton of Lymphoma updated to include histologies 9823 and 9827, except for primary sites C420, C421, C424).

2010 Data Changes:  CCR names (CS TS Ext Eval; Surg Prim Sum; DX Stg Sum) changed to NAACCR names.  Per NAACCR v12.0:

04/2014 Per NAACCR v14, edit retired.